CT3N invites PENN and CHOP researchers to submit competitive proposals for Pilot Grants by December 7, 2018. The goal of these Pilot Grants is to support early‐stage experimental preclinical studies in targeted therapeutics and thus assist investigators in obtaining key data to seek extramural funding. The grants will be for $20,000 for one year.

The scope:

Preclinical (animal, cell culture and in vitro) experimental studies focused on the design of systems for targeted delivery of therapeutics and/or imaging agents and the identification of molecular targets for site‐specific medical interventions.

Proposals in the realms of both adult and pediatric biomedicine, as well as collaborative proposals bridging engineering/material science and biomedical aspects of targeted therapeutics are welcome.

Eligibility:

Applicants must be based in the University of Pennsylvania and be a full‐time faculty of PENN/CHOP. Joint proposals by co‐PIs from PENN /CHOP and CT3N members from other institutions (Drexel, Temple, Jefferson, PSU) will be considered. Applicants must be members of ITMAT and CT3N, and provide a written commitment to CT3N activities including weekly journal club and monthly work‐in‐progress seminars. The PI’s lab can be based at any PENN School or at CHOP. Faculty members from all ranks and tracks are eligible to apply. Investigators in the rank of Senior Investigators and Research Associate may apply on the condition of providing an approval letter from the Department Chair and a letter from the faculty member PI of the lab, assuring that a Research Associate’s project represents an independent new extension of the research area of this lab.

[The deadline for applications is Friday, December 7, 2018 at NOON, for an award start date of February 1, 2019.]

Please direct questions related to eligibility and fit with the scope of CT3N to Dr. Muzykantov, muzykant@mail.med.upenn.edu. Please address questions related to the application process to Charlie Molli, cmolli@upenn.edu.